Fecal transplant

Researchers are beginning to uncover a link between activity level and the microbial makeup of one’s gut.

Recolonizing middle-aged animals with bacteria from younger ones kept killifish alive longer than usual, researchers report.

Fecal transplants from humans with irritable bowel syndrome and anxiety into mice lead to similar symptoms and anxiety-like behavior in the rodents, researchers report.  

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

A bidirectional link between the brain and the gut can improve or worsen brain injury in mice, researchers report.

Donor bacteria coexist with a recipient’s own for three months after a fecal transplant.

Fecal matter transplants may transfer nonpathogenic viruses along with beneficial bacteria, scientists show.

Gastric bypass surgery can have long-term effects on the composition of the gut microbiome, a small study shows.

Gut microbiome analysis reveals protective bacteria that enhance resistance to persistent Clostridium difficile infections.

In a preliminary study, patients with recurring Clostridium difficile infections found relief from diarrhea by ingesting frozen fecal matter from healthy volunteers.

A long-term study confirms transplants of stool microbes from healthy donors can successfully clear recurrent Clostridium difficile infections.

A study shows that fecal transplants in an oral capsule form are an effective treatment for Clostridium difficile infection.

From now on, US physicians and researchers will have to get approval from the FDA before they can perform a stool transplant.

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.